EP2571362A4 - Improved process for a folate-targeted agent - Google Patents

Improved process for a folate-targeted agent

Info

Publication number
EP2571362A4
EP2571362A4 EP11784235.1A EP11784235A EP2571362A4 EP 2571362 A4 EP2571362 A4 EP 2571362A4 EP 11784235 A EP11784235 A EP 11784235A EP 2571362 A4 EP2571362 A4 EP 2571362A4
Authority
EP
European Patent Office
Prior art keywords
folate
improved process
targeted agent
targeted
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11784235.1A
Other languages
German (de)
French (fr)
Other versions
EP2571362A1 (en
Inventor
Daniel S Reno
Katheryn Marie Stanford
Iontcho Radoslavov Vlahov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endocyte Inc
Original Assignee
Endocyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endocyte Inc filed Critical Endocyte Inc
Priority claimed from PCT/US2011/037134 external-priority patent/WO2011146707A1/en
Publication of EP2571362A1 publication Critical patent/EP2571362A1/en
Publication of EP2571362A4 publication Critical patent/EP2571362A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP11784235.1A 2010-05-19 2011-05-19 Improved process for a folate-targeted agent Withdrawn EP2571362A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34644410P 2010-05-19 2010-05-19
US201061351022P 2010-06-03 2010-06-03
PCT/US2011/037134 WO2011146707A1 (en) 2010-05-19 2011-05-19 Improved process for a folate-targeted agent

Publications (2)

Publication Number Publication Date
EP2571362A1 EP2571362A1 (en) 2013-03-27
EP2571362A4 true EP2571362A4 (en) 2014-01-22

Family

ID=47721832

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11784235.1A Withdrawn EP2571362A4 (en) 2010-05-19 2011-05-19 Improved process for a folate-targeted agent

Country Status (1)

Country Link
EP (1) EP2571362A4 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007022493A2 (en) * 2005-08-19 2007-02-22 Endocyte, Inc. Ligand conjugates of vinca alkaloids, analogs, and derivatives
WO2009002993A1 (en) * 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007022493A2 (en) * 2005-08-19 2007-02-22 Endocyte, Inc. Ligand conjugates of vinca alkaloids, analogs, and derivatives
WO2009002993A1 (en) * 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011146707A1 *
VLAHOV I R ET AL: "Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, GB, vol. 16, no. 19, 1 October 2006 (2006-10-01), pages 5093 - 5096, XP027966592, ISSN: 0960-894X, [retrieved on 20061001] *

Also Published As

Publication number Publication date
EP2571362A1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
EP2578832A4 (en) Operation machine
HK1182086A1 (en) Process for making nitriles
GB201011446D0 (en) Process
PL2588273T3 (en) Machine for deep-rolling axles
GB201010439D0 (en) A method
GB201011444D0 (en) Process
EP2684558A4 (en) Skin-beautifying agent
GB201019993D0 (en) Process
ZA201303815B (en) Tunneling machine
PL2545150T3 (en) Process
ZA201303011B (en) Reclaimer machine
EP2674232A4 (en) Bending machine
GB201004301D0 (en) Process
GB201011063D0 (en) Process
GB201009172D0 (en) Process
GB201012418D0 (en) Process
GB201004299D0 (en) Process
HK1167801A1 (en) Head-massaging machine
IL222964A0 (en) Improved process for a folate-targeted agent
GB201016667D0 (en) Idiyappam making machine
PL393225A1 (en) Loading - discharging machine
GB201013180D0 (en) Process
GB201013087D0 (en) Process
GB201011660D0 (en) Process
GB201008462D0 (en) Process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1180902

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20140102

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/48 20060101ALI20131217BHEP

Ipc: C07K 7/02 20060101AFI20131217BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140801

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1180902

Country of ref document: HK